Data scheduled to be published in New England Journal of Medicine, ahead of FDA advisory panel meeting
COVID-19 Vaccine Effectiveness Changing With Delta Predominance
Vaccine protection against SARS-CoV-2 infection declined; protection remained higher against hospitalization, death
Estimated Population Immunity Against SARS-CoV-2 62.0 Percent
Highest population immunity level of 77.2 percent found for adults aged 65 years and older; lowest level of 17.9 percent seen for children younger than 12 years
Risk Factors ID’d for Severe COVID-19 in Children With Cancer
More than half of children and adolescents receiving active oncologic treatment had modifications to cancer-directed therapy
Updated Recommendations for the Prevention and Control of Influenza in Children
The American Academy of Pediatrics (AAP) announced recommendations for the routine use of influenza vaccine and antiviral medications to prevent and treat influenza in children during the 2021–2022 influenza season.
The AAP stated on September 7, 2021, it recommends annual influenza immunization of all children without medical contraindications, starting at six months of age.
Excerpts from the AAP statement are discussed below:
Updated Recommendations for the Prevention and Control of Influenza in Children
The American Academy of Pediatrics (AAP) announced recommendations for the routine use of influenza vaccine and antiviral medications to prevent and treat influenza in children during the 2021–2022 influenza season.
The AAP stated on September 7, 2021, it recommends annual influenza immunization of all children without medical contraindications, starting at six months of age.
Excerpts from the AAP statement are discussed below:
Science Guides the FDA’s COVID-19 Vaccine Decisions for Children
The US Food and Drug Administration (FDA) issued a Statement clarifying lt ‘will follow the science regarding COVID-19 vaccine authorizations for use by young children.’
On September 10, 2021, Dr. Janet Woodcock, Acting Commissioner of FDA, and Peter Marks, M.D., Ph.D., Director – Center for Biologics Evaluation and Research, stated, ‘We know there have been questions and public commentary on the process surrounding vaccines for young children.’
Frequency of Long-Term Symptoms Up With Positive SARS-CoV-2 Test
Persistence of more than four weeks of at least one initially occurring symptom among 76.2 percent of those with positive test
COVAX Cuts Global COVID-19 Vaccine Supply Estimates by a Quarter
United Nations forecast last week that it would have about 25 percent fewer vaccines to distribute through COVAX this year